Nasdaq

Jasper Therapeutics Reports Promising BEACON Study Results for Briquilimab in Chronic Spontaneous Urticaria Amid Drug Product Lot Investigation

Jasper Therapeutics, Inc. announced promising results from its BEACON Phase 1b/2a study of briquilimab, an antibody therapy targeting mast cell diseases like chronic spontaneous urticaria (CSU). In ...
Nasdaq

Jasper Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel ...
WTOC-TV

New detailed report alleges former Jasper County Superintendent’s ‘shocking and disheartening’ misconduct

JASPER COUNTY, S.C. (WTOC) - When the Jasper County School District parted ways with their superintendent within the last year, rumors swirled around the Lowcountry. SEE: Jasper County Superintendent ...
Yahoo

Jasper County Sheriff publishes 2024 year-end report

Add Yahoo as a preferred source to see more of our stories on Google. Jan. 20—By the numbers Total number of calls for service, patrol division: 2024: 34,741 2023: 31,003 2022: 29,133 2021: 29,909 ...
Yahoo Finance

Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody ...
Yahoo Finance

Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE)-- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel ...